BioBridge® Collagen Matrix receives 510(k) clearance

Jan 12, 2016

Fibralign’s first product, the BioBridge® Collagen Matrix has received 510(k) clearance from the FDA on January 07, 2016 for use in soft tissue support/repair (K151083). Click to view.

BioBridge is a sterile thread-like surgical mesh designed for use in surgery to reinforce and repair soft tissue where weakness and deficiencies exist. This novel medical device is made of highly purified aligned collagen fibrils and created using Fibralign’s patented Nanoweave® technology.

BioBridge was shown in a published preclinical study with Stanford University to support and promote the formation of new lymphatic vessels (lymphangiogenesis).*

* The FDA has not approved BioBridge for the treatment of lymphedema.

AngelMD Closes Syndicate Funding Round in Fibralign

AngelMD Closes Syndicate Funding Round in Fibralign

AngelMD,an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners, today announced that it has completed a Syndicate funding round for Fibralign, Inc. Fibralign produces therapeutic medical devices that...

read more